Cecal ligation and puncture versus colon ascendens stent peritonitis:: Two distinct animal models for polymicrobial sepsis

被引:185
作者
Maier, S
Traeger, T
Entleutner, M
Westerholt, A
Kleist, B
Hüser, N
Holzmann, B
Stier, A
Pfeffer, K
Heidecke, CD
机构
[1] Ernst Moritz Arndt Univ Greifswald, Chirurg Klin & Poliklin, Dept Surg, D-17487 Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Chirurg Klin & Poliklin, Inst Pathol, D-17487 Greifswald, Germany
[3] Tech Univ Munich, Dept Surg, D-8000 Munich, Germany
[4] Univ Dusseldorf, Inst Med Microbiol & Virol, D-4000 Dusseldorf, Germany
来源
SHOCK | 2004年 / 21卷 / 06期
关键词
sepsis; peritonitis; shock; animal model; mice; CASP; CLP;
D O I
10.1097/01.shk.0000126906.52367.dd
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Colon ascendens stent peritonitis (CASP) and cecal ligation and puncture (CLIP), two animal models designed to closely mimic the clinical course of intra-abdominal sepsis, were compared. In the past, immunomodulatory therapies developed in animal studies failed to be successful in humans. As a consequence, the established animal sepsis models were criticized. It has been proposed that present models had to be reevaluated, and new, clinically more relevant models should be evolved. CLP procedure was performed puncturing once (CLP[l]) or twice (CLP[2]) the ligated cecum of C57BL/6 mice. In the CASP model, a stent with defined diameter was surgically inserted into the ascending colon. Survival, bacterial load, immunohistochemistry, and serum cytokine levels were analyzed in the groups. Survival after CASP procedure correlated strongly with the stent diameter, whereas the number of punctures in CLP did not significantly change survival rate. Bacterial loads of peritoneal lavage, liver, and lung, as well as serum cytokine levels (tumor necrosis factor, interleukin 10, interleukin 10) steadily increased from 6 to 24 h after the CASP procedure. In contrast, continuously low amounts of bacteria and cytokines were found in CLP mice at any point of time. Twenty-four hours after CLP surgery, the ligated cecum was covered by adhesive small bowel loops, whereas in CASP mice, the intestinal leakage was then still present. The CASP model mimics closely the clinical course of diffuse peritonitis with early and steadily increasing systemic infection and inflammation (systemic inflammatory response syndrome). In contrast, CLP reveals a model of intra-abdominal abscess formation with sustained and minor signs of systemic inflammation.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 49 条
[21]   Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: High serum IL-18 as an early predictive indicator of lethal outcome [J].
Emmanuilidis, K ;
Weighardt, H ;
Matevossian, E ;
Heidecke, CD ;
Ulm, K ;
Bartels, H ;
Siewert, JR ;
Holzmann, B .
SHOCK, 2002, 18 (04) :301-305
[22]  
ESKANDARI MK, 1992, J IMMUNOL, V148, P2724
[23]   LABORATORY MODELS OF SEPSIS AND SEPTIC SHOCK [J].
FINK, MP ;
HEARD, SO .
JOURNAL OF SURGICAL RESEARCH, 1990, 49 (02) :186-196
[24]   Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein [J].
Fisher, CJ ;
Agosti, JM ;
Opal, SM ;
Lowry, SF ;
Balk, RA ;
Sadoff, JC ;
Abraham, E ;
Schein, RMH ;
Benjamin, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1697-1702
[25]   RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISHER, CJ ;
DHAINAUT, JFA ;
OPAL, SM ;
PRIBBLE, JP ;
BALK, RA ;
SLOTMAN, GJ ;
IBERTI, TJ ;
RACKOW, EC ;
SHAPIRO, MJ ;
GREENMAN, RL ;
REINES, HD ;
SHELLY, MP ;
THOMPSON, BW ;
LABRECQUE, JF ;
CATALANO, MA ;
KNAUS, WA ;
SADOFF, JC ;
ASTIZ, M ;
CARPATI, C ;
BONE, RC ;
FREIDMAN, B ;
MURE, AJ ;
BRATHWAITE, C ;
SHAPIRO, E ;
MELHORN, L ;
TAYLOR, R ;
KEEGAN, M ;
OBRIEN, J ;
SCHEIN, R ;
PENA, M ;
WASSERLOUF, M ;
OROPELLO, J ;
BENJAMIN, E ;
DELGUIDICE, R ;
EMMANUEL, G ;
LIE, T ;
ANDERSON, L ;
MARSHALL, J ;
DEMAJO, W ;
ROTSTEIN, O ;
FOSTER, D ;
ABRAHAM, E ;
MIDDLETON, H ;
PERRY, C ;
LEVY, H ;
FRY, DE ;
SIMPSON, SQ ;
CROWELL, RE ;
NEIDHART, M ;
STEVENS, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1836-1843
[26]   INITIAL EVALUATION OF HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF SEPSIS SYNDROME - A RANDOMIZED, OPEN-LABEL, PLACEBO-CONTROLLED MULTICENTER TRIAL [J].
FISHER, CJ ;
SLOTMAN, GJ ;
OPAL, SM ;
PRIBBLE, JP ;
BONE, RC ;
EMMANUEL, G ;
NG, D ;
BLOEDOW, DC ;
CATALANO, MA ;
FRIEDMAN, B ;
MURE, A ;
SHAPIRO, E .
CRITICAL CARE MEDICINE, 1994, 22 (01) :12-21
[27]   INTERFERON-GAMMA, A MEDIATOR OF LETHAL LIPOPOLYSACCHARIDE-INDUCED SHWARTZMAN-LIKE SHOCK REACTIONS IN MICE [J].
HEREMANS, H ;
VANDAMME, J ;
DILLEN, C ;
DIJKMANS, R ;
BILLIAU, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (06) :1853-1869
[28]  
Khurrum Baig M, 2002, Tech Coloproctol, V6, P159
[29]  
LEVISON MA, 1992, INFECT DIS CLIN N AM, V6, P525
[30]  
LINDER MM, 1987, CHIRURG, V58, P84